Why is MMTX.SW stock falling pre-market today?

MMTX.SW stock is down pre-market due to technical selling, trading below the 50-day and 200-day averages and heavy volume of **484,674** shares. Low liquidity and lack of visible earnings can magnify declines on the SIX market.

What is Meyka AI's grade for MMTX.SW stock and what does it mean?

Meyka AI rates MMTX.SW with a score out of 100: **62.72 (Grade B, HOLD)**. The grade combines benchmark, sector, growth metrics and analyst inputs. It is informational and not investment advice.

What short-term price action should traders watch for MMTX.SW stock?

Traders should watch support at **CHF 0.45** and the intraday range **CHF 0.452–CHF 0.51**. RSI **10.54** and oversold oscillators signal potential quick bounces but also high downside risk.

Does Meyka AI provide a price forecast for MMTX.SW stock?

Yes. Meyka AI's forecast model projects **CHF 0.03** in one month versus the current **CHF 0.452**, implying **-93.36%** downside. Forecasts are model-based projections and not guarantees.

CH Stocks

Pre-market top loser: MMTX.SW MindMaze Therapeutics (SIX) -7.09% 12 Mar 2026: watch CHF 0.45 support

ByDanny Kontos March 12, 2026March 12, 2026

MMTX.SW stock leads pre-market decliners on 12 Mar 2026 after sliding -7.09% to CHF 0.452 following a weak open at CHF 0.51. Trading volume at 484,674 shares already exceeds the average of 436,174, signalling active selling in Lausanne-listed MindMaze Therapeutics (SIX). Year-to-date performance shows a sharp decline of -70.84%, and intraday price sits at the 52-week low of CHF 0.452. Investors should watch short-term support near CHF 0.45 while we outline technical drivers, fundamentals and Meyka AI model forecasts below.